These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 17044598)

  • 1. [The lipoprotein metabolism in arterial hypertension, type II diabetes mellitus, and metabolic syndrome].
    Bozhko GKh; Sokolik VV; Chursina VS; Pertseva TG
    Biomed Khim; 2006; 52(4):394-402. PubMed ID: 17044598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of circulating lipoprotein lipase and adiponectin on the particle size of remnant lipoproteins in patients with diabetes mellitus and metabolic syndrome.
    Shirakawa T; Nakajima K; Yatsuzuka S; Shimomura Y; Kobayashi J; Machida T; Sumino H; Murakami M
    Clin Chim Acta; 2015 Feb; 440():123-32. PubMed ID: 25445417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in the lipoprotein metabolism in alcoholism do not recover during of prolonged remission].
    Bozhko GKh; Sokolik VV; Chursina VS; Artemchuk AF
    Biomed Khim; 2006; 52(2):192-9. PubMed ID: 16805392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.
    Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute dyslipoproteinemia induced by interleukin-2: lecithin:cholesteryl acyltransferase, lipoprotein lipase, and hepatic lipase deficiencies.
    Kwong LK; Ridinger DN; Bandhauer M; Ward JH; Samlowski WE; Iverius PH; Pritchard H; Wilson DE
    J Clin Endocrinol Metab; 1997 May; 82(5):1572-81. PubMed ID: 9141552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The majority of lipoprotein lipase in plasma is bound to remnant lipoproteins: A new definition of remnant lipoproteins.
    Sato K; Okajima F; Miyashita K; Imamura S; Kobayashi J; Stanhope KL; Havel PJ; Machida T; Sumino H; Murakami M; Schaefer E; Nakajima K
    Clin Chim Acta; 2016 Oct; 461():114-25. PubMed ID: 27342999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum amyloid A is found on ApoB-containing lipoproteins in obese humans with diabetes.
    Jahangiri A; Wilson PG; Hou T; Brown A; King VL; Tannock LR
    Obesity (Silver Spring); 2013 May; 21(5):993-6. PubMed ID: 23784902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Apolipoproteins A and B in cerebrovascular diseases].
    Bruck J; Fischer M; Sluga E; Tschabitscher H
    Nervenarzt; 1985 Feb; 56(2):89-93. PubMed ID: 3982568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipid metabolism in patients with type 2 diabetes mellitus with and without the metabolic syndrome].
    Kulieva NF
    Georgian Med News; 2009 Jan; (166):58-60. PubMed ID: 19202221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Depression of serum esterase and lipoprotein lipase activities in acute and longitudinal actions of ethanol].
    Sokolik VV; Chursina VS; Artemchuk AA; Artemchuk AF; Bozhko GKh
    Biomed Khim; 2006; 52(1):95-100. PubMed ID: 16739925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
    Stanely Mainzen Prince P; Kannan NK
    J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome].
    Breier C; Lisch HJ; Drexel H; Braunsteiner H
    Schweiz Med Wochenschr; 1983 Jun; 113(25):909-13. PubMed ID: 6612272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profile.
    Dullaart RP; Constantinides A; Perton FG; van Leeuwen JJ; van Pelt JL; de Vries R; van Tol A
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1077-84. PubMed ID: 21252249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension.
    Saiki A; Ohira M; Endo K; Koide N; Oyama T; Murano T; Miyashita Y; Shirai K
    Diabetes Res Clin Pract; 2006 Dec; 74(3):242-8. PubMed ID: 16713009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma.
    Steyrer E; Durovic S; Frank S; Giessauf W; Burger A; Dieplinger H; Zechner R; Kostner GM
    J Clin Invest; 1994 Dec; 94(6):2330-40. PubMed ID: 7989589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
    Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.